PDPRIMER

"1.Peritoneal Dialysis -what you need for the on call night Summer Emergency Lecture Series",
"2.Outline",
"3.Composition of Peritoneal Dialysate",
"4.Peritoneal Dialysis Catheter",
"5.",
"6.PD Catheter in situ",
"7.Anatomy of the Peritoneal Membrance",
"8.Peritoneal Blood Flow",
"9.Solute Flux",
"10.Diffusion Kinetics",
"11.Diffusion Kinetics",
"12.Diffusion Kinetics-from blood to dialysate",
"13.The Three Pore Model",
"14.Diffusion Curves",
"15.Outline",
"16.Ultrafiltration",
"17.Composition of Peritoneal Dialysate Osmolality",
"18.Ultrafiltration",
"19.Ultrafiltration",
"20.Ultrafiltration:4.25% Dialysate",
"21.Ultrafiltration",
"22.Ultrafiltration in Peritoneal Dialysis",
"23.Typical Ultrafiltration Curves for Each Strength of Dialysate",
"24.Ultrafiltration in Peritoneal Dialysis",
"25.Ultrafiltration in Peritoneal Dialysis",
"26.Ultrafiltration in Peritoneal Dialysis",
"27.Ultrafiltration in Peritoneal Dialysis",
"28.Outline",
"29.Writing PD Orders-what's what!",
"30.Writing PD Orders",
"31.Writing PD Orders",
"32.Writing PD Orders - WHat is added TO Dialysate",
"33.Writing Dialysis Orders - How to Increase Ultrafiltration",
"34.Writing Dialysis Orders - How to Increase Ultrafiltration",
"35.Writing Dialysis Orders - How to Increase Ultrafiltration",
"36.Icodextrin(con't d)",
"37.Icodextrin(con't d)",
"38.Icodextrin(con't d)",
"39.",
"40.Icodextrin-a Caultionary Note",
"41.Outline",
"42.",
"43.Peritonitis-Diagnosis",
"44.Peritonitis-Differential Diagnosis",
"45.Peritonitis-Differential Diagnosis",
"46.Peritonitis-Differential Diagnosis",
"47.Flush Before Fill and the reduction in peritonitis rates",
"48.The Old Connectology",
"49.The Old Connectology",
"50.The Old Connectology",
'51.The New Connectology:"Flush Before Fill"',
'52.The New Connectology:"Flush Before Fill"',
'53.The New Connectology:"Flush Before Fill"',
'54.The New Connectology:"Flush Before Fill"',
'55.Peritonitis-Principles of Treatment',
'56.Peritonitis-Special Situations',
'57.Peritonitis-Other Suggestions',
'58.Peritonitis-Principles of Treatment',
'59.Peritonitis-Indications for Catheter Removal',
'60.Peritonitis-Indications for Catheter Removal',
'61.Peritonitis-Complications',
'62.ISPD Guidelines:Empiric Antibiotic Therapy',
'63.ISPD Guidelines:Empiric Antibiotic Therapy',
'64.If Culture Grows Coagulase Negative Staphylococcus',
'65.If Culture Grows Staphylococcus Aureus:',
'66.If Culture Grows Enterococcus:'
'67.If Single Gram Negative Organism Cultured(non Pseudomonas)',
'68.If Culture Grows Pseudomonas/Stenotrophomonas',
'69.If Culture Grows Multiple Gram Negative Organism +/- Anaerobes',
'70.If Yeast or Other Fungus Reported:',
'71.If Culture is Negative:',
'72.',
'73.Exit Site and Tunnel Infections',
'74.Exit Site and Tunnel Infections',
'75.Exit Site and Tunnel Infections',
'76.Exit Site and Tunnel Infections',
'77.Summary 1 of 2',
'78.Summary 2 of 2',

POIS

'1.August 2008',
'2.Agenda',
'3.What Factors Delermine Whether a Drug/Toxin Should be Removed by Dialysis?'
'4.What is a "Small" Molecule?',
'5.What is a "Small" Molecule?',
'6.The Ideal Toxin for Dialysis',
'7.Case',
'8.Analysis',
'9.Dialyzable Toxins and Their Frequency',
'10.Methanol',
'11.',
'12.Methanol Metabolism',
'13.Methanol and Metabolites',
'14.Clinical Manifestations',
'15.Physical Findings',
'16.Laboratory Changes',
'17.Case Review',
'18.Differential Diagnosis',
'19.Pitfalls Diagnosis(1)',
'20.Methanol and AG vs Time',
'21.Pitfalls in Diagnosis 2',
'22.Diagnosis',
'23.Treatment',
'24.Treatment of Acidosis',
'25.How Much Bicarbonate?',
'26.Inhibit Alcohol Dehydrogenase',
'27.Dialysis for Formate and Methanol',
'28.Dialysis',
'29.Outcome',
'30.',
'31.Ethylene Glycol(Antifreeze)',
'32.Lithium',
'33.Lithium Toxicity - Manifestations',
'34.Is Dialysis Effective?',
'35.Indications for Dialysis',
'36.Dialysis for Lithium',
'37.Is Rebound Likely?',
'38.What are Determinants of Rebound?',
'39.What Happened to Blood Li?',
'40.Rx of servere Li Poisoning with HD then CVVHD',
'41.Salicylates',
'42.Is HD Useful for Salicylate Poisoning?',
'43.Salicylate-Indications for HD',
'44.Other Toxins That May be Dialyzed',
'45.Hemoperfusion'

PPFHD...

'1.Past Present and Future of Hemodialysis November 2006',
'2.The Past',
'3.TECHNOLOGICAL BARRIERS',
'4.Early History of Dialysis',
'5.Early History of Dialysis(2)',
'6.Cellophane',
'7.Early History of Dialysis(3)',
'8.Early History of Dialysis(4)',
'9.Modem Era of Hemodialysis Access',
'10.',
'11.',
'12.Modem Era of Hemodialysis Access(2)',
'13.Access',
'14.Other Technological Advances',
"15.1990's:Computerization",
"16.Recognition of Long Term Complications",
"17.Recognition of Long Term Complications(2)",
"18.The Present",
'19.Prevalent ESRD Patients at Year-end, Canada, 1981-2002(Number)',
"20.Renal Transplants, 1 Canada 1994-2003(Number)",
"21.Current HD Machines",
"22.Current Problems with Hemodialysis",
'23.CORR 2002 Survial in Males on HD',
'24.CORR 2002 Survial in Women 65+ YRS',
'25.CORR 2000 ESRD Mortality By Inception Cohort',
'26.Why Such High Mortality?',
'27.Why Improving Mortality?',
'28.Future in HD 1.Dialysis Adequacy',
'29.Present and Future in HD 1.Dialysis Adequacy(2)',
'30.Present and Future in HD 1.Dialysis Adequacy(3)',
'31.Present and Future in HD 1.Dialysis Adequacy(4)',
'32.Present and Future in HD 2.Vascular Access',
'33.Future in HD Other Issues',
'34.Dialysis for Acute Renal Failure',
'35.Summary'
